Raisio, Finland

Lauri V Kangas

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lauri V Kangas. Retrieved from https://idiyas.com/inventor/lauri-v-kangas-cbu9zpqc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 42(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lauri V Kangas: Innovator in Cancer Treatment

Introduction

Lauri V Kangas is a notable inventor based in Raisio, Finland. He has made significant contributions to the field of cancer treatment through his innovative research and patent.

Latest Patents

Lauri V Kangas holds a patent for the use of toremifene and its metabolites for the reversal of multidrug resistance in cancer cells. This invention relates to the application of a compound comprising toremifene or its metabolites, such as N-demethyltoremifene or 4-hydroxytoremifene, or their non-toxic pharmaceutically acceptable salts. The goal of this invention is to enhance the effectiveness of cytotoxic drugs in cancer treatment.

Career Highlights

Throughout his career, Lauri V Kangas has focused on developing solutions that address critical challenges in cancer therapy. His work has the potential to improve treatment outcomes for patients facing multidrug resistance.

Collaborations

Lauri has collaborated with esteemed colleagues, including Adrian Llewllyn Harris and Michael W DeGregorio, to advance his research and innovations in the field.

Conclusion

Lauri V Kangas is a dedicated inventor whose work in cancer treatment exemplifies the impact of innovative research on healthcare. His contributions continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…